Chargement en cours...
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at doses of 60 mg daily. Duloxetine has been shown to significantly improve the symptoms of chronic pain associated with these...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048581/ https://ncbi.nlm.nih.gov/pubmed/21386950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S12866 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|